Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

mapping the sequence determinants of protein stability and its contribution to rare genetic diseases

Objective

Missense variants cause nearly one-third of all human genetic diseases, yet most have unknown functional consequences. Computational predictors can flag pathogenic variants, but they remain blind to mechanism—whether a mutation destabilizes a protein, mislocalizes it, or alters its interactions. Without mechanism, variant interpretation is incomplete and therapeutic opportunities remain hidden. I previously developed deep mutational scanning (DMS) methods to quantify the effects of >500,000 variants on the stability of >500 human protein domains, revealing that ~50% of pathogenic variants destabilize proteins. Yet this still covers barely 1% of domains and 2% of unique folds in human. Most of the proteome—including most rare disease proteins—remains experimentally unexplored.
Here, we will expand this approach to decode how protein stability is encoded in sequence and how its loss contributes to rare genetic diseases. Specifically, we will:

1) Chart the landscape of protein fold stability — generating the broadest DMS survey of fold space to date, covering 800 unique folds to uncover the sequence determinants of stability and refine predictive models.
2) Expand stability mapping to full-length proteins in human cells — by generating DMS maps across 500 rare disease proteins, we will reveal how mutations in domains, linkers, and disordered regions shape protein abundance in cells, and test the specificity of stabilizer drugs.
3) Dissect how the proteostasis network shapes disease variant outcomes —by systematically mapping how chaperones and degradation pathways interact with mutations, we will reveal variants whose effects emerge under proteostasis decline.

These datasets will serve as reference atlases for clinical variant interpretation across rare diseases— defining which are ‘folding diseases’, and which pathogenic variants are destabilizing—and collectively transform our understanding of how protein stability—and its failure—is encoded in the human genome.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2026-STG

See all projects funded under this call

Host institution

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Net EU contribution
€ 1 625 000,00
Address
CALLE SERRANO 117
28006 Madrid
Spain
Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Research Organisations
Links
Total cost
€ 1 625 000,00

Beneficiaries (1)